Ergawealth Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$412K Hold
20,100
0.16% 35
2026
Q1
$443K Hold
20,100
0.2% 34
2025
Q4
$237K Hold
20,100
0.11% 48
2025
Q3
$318K Hold
20,100
0.15% 42
2025
Q2
$230K Buy
20,100
+5,000
+33% +$56.3K 0.1% 62
2025
Q1
$204K Hold
15,100
0.1% 59
2024
Q4
$255K Hold
15,100
0.13% 58
2024
Q3
$307K Hold
15,100
0.15% 50
2024
Q2
$341K Hold
15,100
0.19% 48
2024
Q1
$397K Hold
15,100
0.22% 41
2023
Q4
$476K Hold
15,100
0.29% 29
2023
Q3
$424K Hold
15,100
0.29% 28
2023
Q2
$557K Hold
15,100
0.38% 23
2023
Q1
$452K Hold
15,100
0.37% 23
2022
Q4
$462K Buy
+15,100
New +$453K 0.42% 24

Other funds holding CC

Ergawealth Advisors's CC Position: Q2 2026 in Review

Ergawealth Advisors held its Chemours (CC) position steady in Q2 2026 at 20,100 shares worth $412K. The position accounts for 0.16% of the portfolio, ranked #35.

Ergawealth Advisors first reported a position in CC in Q4 2022 and has held it in 15 quarters since. The position peaked at $557K in Q2 2023. 473 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Ergawealth Advisors held 20,100 shares of Chemours worth $412K as of Q2 2026.
  • Ergawealth Advisors left its Chemours share count unchanged in Q2 2026.
  • Chemours made up 0.16% of Ergawealth Advisors's portfolio in Q2 2026, its #35 holding.
  • Ergawealth Advisors first reported a position in Chemours in Q4 2022 and has held it in 15 quarters since.
  • Ergawealth Advisors's Chemours position peaked at $557K in Q2 2023.
  • 473 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Ergawealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.